Emerging Southeast Asian PfCRT Mutations Confer Plasmodium Falciparum Resistance to the First-Line Antimalarial Piperaquine

Nature Communications - United Kingdom
doi 10.1038/s41467-018-05652-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Chloroquine Resistance in Plasmodium Falciparum Malaria Parasites Conferred by PFCRT Mutations

Science
MultidisciplinaryPhilosophy of ScienceHistory
2002English

Evidence for a Central Role for PfCRT in Conferring Plasmodium Falciparum Resistance to Diverse Antimalarial Agents

Molecular Cell
Cell BiologyMolecular Biology
2004English

Piperaquine Resistance in Plasmodium Falciparum, West Africa

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2018English

Prevalence of Plasmodium Falciparum Antimalarial Drug Resistance Genes in Southeastern Gabon From 2011 to 2014

Infection and Drug Resistance
Infectious DiseasesPharmacology
2018English

PFCRT and Pfmdr1 Alleles Associated With Chloroquine Resistance in Plasmodium Falciparum From Guyana, South America

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2004English

Transformation of Plasmodium Falciparum Malaria Parasites by Homologous Integration of Plasmids That Confer Resistance to Pyrimethamine.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Global Spread of Mutant PfCRT and Its Pleiotropic Impact on Plasmodium Falciparum Multidrug Resistance and Fitness

mBio
VirologyMicrobiology
2019English

Escalating Plasmodium Falciparum Antifolate Drug Resistance Mutations in Macha, Rural Zambia

Malaria Journal
ParasitologyInfectious Diseases
2008English

In Vitro Sensitivities of Plasmodium Falciparum to Different Antimalarial Drugs in Uganda

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy